NO895041L - Fremgangsmaate for fremstilling av prolegemidler av 3,4-hydroxybenzyloxypropanolaminer. - Google Patents

Fremgangsmaate for fremstilling av prolegemidler av 3,4-hydroxybenzyloxypropanolaminer.

Info

Publication number
NO895041L
NO895041L NO89895041A NO895041A NO895041L NO 895041 L NO895041 L NO 895041L NO 89895041 A NO89895041 A NO 89895041A NO 895041 A NO895041 A NO 895041A NO 895041 L NO895041 L NO 895041L
Authority
NO
Norway
Prior art keywords
straight
proluments
hydroxybenzyloxypropanolamines
procedure
preparation
Prior art date
Application number
NO89895041A
Other languages
English (en)
Norwegian (no)
Other versions
NO895041D0 (no
Inventor
Ghanshyam Patil
William L Matier
Khuong H X Mai
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of NO895041D0 publication Critical patent/NO895041D0/no
Publication of NO895041L publication Critical patent/NO895041L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/14—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
NO89895041A 1988-12-15 1989-12-14 Fremgangsmaate for fremstilling av prolegemidler av 3,4-hydroxybenzyloxypropanolaminer. NO895041L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/285,006 US4897417A (en) 1988-12-15 1988-12-15 Prodrugs of 3,4-hydroxy benzoyloxypropanolamines

Publications (2)

Publication Number Publication Date
NO895041D0 NO895041D0 (no) 1989-12-14
NO895041L true NO895041L (no) 1990-06-18

Family

ID=23092341

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89895041A NO895041L (no) 1988-12-15 1989-12-14 Fremgangsmaate for fremstilling av prolegemidler av 3,4-hydroxybenzyloxypropanolaminer.

Country Status (16)

Country Link
US (1) US4897417A (fi)
EP (1) EP0373590B1 (fi)
JP (1) JPH0653714B2 (fi)
AT (1) ATE102182T1 (fi)
AU (1) AU619367B2 (fi)
CA (1) CA2005373A1 (fi)
DE (1) DE68913462T2 (fi)
DK (1) DK633989A (fi)
FI (1) FI895977A0 (fi)
HU (1) HU203222B (fi)
IL (1) IL92649A0 (fi)
NO (1) NO895041L (fi)
NZ (1) NZ231752A (fi)
PT (1) PT92589B (fi)
RU (1) RU1795966C (fi)
ZA (1) ZA899619B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966914A (en) * 1988-12-15 1990-10-30 E. I. Du Pont De Nemours And Company Oculoselective beta-blockers as antiglaucoma agents
US4935422A (en) * 1988-12-15 1990-06-19 E. I. Du Pont De Nemours And Company Acyloxypropanolamines
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US6765019B1 (en) 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
AU2005247480A1 (en) * 2004-05-25 2005-12-08 Qlt Inc. Oculoselective drugs and prodrugs
CA2680843C (en) 2007-01-29 2016-05-31 Vlife Sciences Technologies Pvt. Ltd. Pharmaceutical composition for treatment of diabetic complications
WO2010016044A1 (en) * 2008-08-05 2010-02-11 University College Cork, National University Of Ireland, Cork Treatment of retinal degeneration
CN104387265B (zh) * 2014-10-30 2016-10-26 盐城师范学院 一种4,5-二羟基-2-甲基苯甲酸的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195085A (en) * 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4402974A (en) * 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4582855A (en) * 1981-11-12 1986-04-15 American Hospital Supply Corporation Aromatic and esters of hydroxypropylamines
DE3380093D1 (en) * 1982-09-30 1989-07-27 William John Louis 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
US4579867A (en) * 1984-04-09 1986-04-01 American Hospital Supply Corporation Stable pharmaceutical compositions of short-acting β-adrenergic receptor blocking agents

Also Published As

Publication number Publication date
DK633989A (da) 1990-06-16
US4897417A (en) 1990-01-30
NO895041D0 (no) 1989-12-14
AU619367B2 (en) 1992-01-23
PT92589B (pt) 1995-09-12
ZA899619B (en) 1991-08-28
EP0373590A3 (en) 1991-03-27
HU896641D0 (en) 1990-02-28
PT92589A (pt) 1990-06-29
EP0373590A2 (en) 1990-06-20
HUT53065A (en) 1990-09-28
DE68913462D1 (de) 1994-04-07
CA2005373A1 (en) 1990-06-15
ATE102182T1 (de) 1994-03-15
IL92649A0 (en) 1990-08-31
RU1795966C (ru) 1993-02-15
DE68913462T2 (de) 1994-07-14
EP0373590B1 (en) 1994-03-02
DK633989D0 (da) 1989-12-14
HU203222B (en) 1991-06-28
JPH02258751A (ja) 1990-10-19
AU4679989A (en) 1990-06-21
NZ231752A (en) 1991-03-26
JPH0653714B2 (ja) 1994-07-20
FI895977A0 (fi) 1989-12-14

Similar Documents

Publication Publication Date Title
NO941884D0 (no) 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler
NO895041L (no) Fremgangsmaate for fremstilling av prolegemidler av 3,4-hydroxybenzyloxypropanolaminer.
DE69329982D1 (de) 4-Carboxyimidazolderivate als Angiotensin-II-Antagonisten und ihre therapeutische Verwendung
NO895042D0 (no) Fremgangsmaate for fremstilling av oculoselektive beta-blokkere som antiglaucoma midler.
AU4720389A (en) N-pyridinyl-9h-carbazol-9-amines, a process their preparation and their use as medicaments
AU4679789A (en) Acyloxypropanolamines
FI944687A (fi) Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi
EP0647636A4 (fi)